WTI,WT1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ß¦Ã-Çòµ°°×Ѫ֢,hypergammaglobulinemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾ÞÓ׺ìϸ°û,macrocyteÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ß°×ϸ°û,HyperleukocyteÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« N-¼×»ù-N-ÑÇÏõ»ùëå/MNU,N-methyl-N-nitrosourea/MNUÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾ÞºËϸ°ûÉú³É,megakaryopoiesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ĤÌúתÔ˵°°×,ferroportinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½áÄÚ,nodalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºËÌÒõ«,JugloneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µÍÑõÓÕµ¼Òò×Ó-1(HIF-1),HEF-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÀÍв´ÜÕ(VP-16),RajiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« MN1»ùÒò,MN1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« GLIPR1,5-ÔÓµª-2'-ÍÑÑõ°ûÜÕ,GLIPR1,5-aza-2'-deoxycitydineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« PPAR¦ÃÅäÌå,PPAR¦ÃligandÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔçÓ×Á£Ï¸°û°×Ѫ²¡»ùÒò(PML)±äÒìÌå,Mut-PMLÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿ÉÈÜÐ͸Éϸ°ûÒò×Ó,s-SCFÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« TCR¦ÆÁ´»ùÒò,TCR¦ÆchainÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« AML-M2ÐÎ̬ѧ,AML-M2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸»ÓÚTϸ°û/×é֯ϸ°ûµÄBϸ°ûÁܰÍÁö,T/HRBCLÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 13q14.3λµã,13q14.3situsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϸ°û-SELEX,Cell-SELEXÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Tϸ°ûÊÜÌå¦ÃÁ´,¦ÃchainÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 12-Ñõ-Ê®ËÄÍéõ£´¼-13-ÒÒËáõ¥,12-O-tetradecanoylphorbol-13-acetateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ð¤Ä¤Ïà¹ØÁܰÍÁöÒ×λ»ùÒò1,MALT1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« À×Àû¶È°·,lenalidomideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« º£Ãà×´/³¬Éù¼ì²é,cavernous/ultrasonographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« JAK¼Ò×å»ùÒò,JAKsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »ûÌ¥ÁöÑÜÉúÉú³¤Òò×Ó-1,Cripto-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼×»ù»¯/È¥¼×»ù»¯,methylation/demethylationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´ó»ÆËØ/Ò©Àíѧ,emodin/pharmacologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ËèÑù/°×Ѫ²¡,mgeloid/leukemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »ìºÏÆ×ϵ°×Ѫ²¡µ°°×,MLLÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶à·¢ÐÔÄÚ·ÖÃÚ°©µ°°×,MeninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ÇÖÊÈܽâ/²¡Òòѧ,Osteolysis/etioloÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« СéÞ°·/ͶҩºÍ¼ÁÁ¿,BERBAMINE/adminÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼±ÐÔ/ÃâÒßѧ,acute/immuonologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¦¶¾ËØÀà/Öж¾,enterotoxins/poisoningÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϵĤ,MesocolonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °²Ñ¾à¤,AmsacrineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼¡´¼5'Á×Ëáø,SIHPÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« SNPоƬ,SNP-arraysÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 13ºÅȾɫÌåȱʧ,Del(13q)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½üËı¶Ìå,Near-tetraploidyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¦Ã-·ÖÃÚøÒÖÖÆ¼ÁDAPT,DAPTÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 5-Ï©±û»ù-7-¶þ·ú¼×»ù°×ÑîËØ,5-ally-7-gen-difluormethylenochrysinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²¢ÖÃÐÔ×÷ÓÃ,juxtacrineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Tϸ°ûÄÚ¿¹Ô­(TIA-1),TIA-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á£-µ¥ºËϸ°û°×Ѫ²¡,MyelomonocyticleukemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¥ºËϵ,monocyticÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ë«ÓÕµ¼,Bi-inductionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏÙ°©,adenocarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °©,CarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¨²¬,CarboplatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÊÐÎ,conformalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºçĤ,irisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ë÷À­·ÇÄá,SorafenibÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °©ÈâÁö,CarcinosarcomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶àÏ©×Ïɼ´¼,docetaxelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« åçÐÇ,cometÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Â岬,lobaplatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁܰͽáÇåɨÊõ,LymphadenectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×Ïɼ·Ó,PaclitaxelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ŵµÛ,NordyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉÏÆ¤¸ÆÕ³µ°°×,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Àä¶³Íâ¿Æ,cryosurgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¦Ã-ÉäÏß,¦Ã-rayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉúÎïѧ·Ö²¼,biodistributionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉÏÆ¤Ñù,epithelioidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Æ«Àë,deviationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁܰͽáÇгýÊõ,lymph node excisionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ͬ²½·Å»¯ÁÆ,Concurrent chemoradiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÂÈÈ,HyperthermiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Áܰ͹ÜÐγÉ,lymphangiogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ÂÁ¢ÐÔ,SolitaryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ezrinµ°°×,EzrinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ûºÏÏß·,CoincidenceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×ªÒÆÐÔ,metastaticÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌæÄá²´ß°,TeniposideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á¬»·µ°°×,cateninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐûÍþ,XuanweiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ÇÈâÁö/²¡Àíѧ,osteosarcoma/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò×Èðɳ,IressaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö§Æø¹Ü³ÉÐÎÊõ,BronchoplastyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °ëë×°±Ëáµ°°×ø,CaspaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉÏÆ¤Ð͸Æð¤µ°°×,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µÍ¹à×¢,hypoperfusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ÷Ç¿ÊÊÐÎ,intensity-modulatedÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·´Ïò´«²¥,back propagationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« à­ßòßøÀà,quinazolinesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« E-cad,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö§Æø¹Ü³ÉÐÎ,BronchoplastyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ë«»·²¬,dicycloplatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« E¸ÆÕ³µ°°×,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ¹ÜÄÚÆ¤Éú³¤Òò×Ó-D,VEGF-DÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×ÏɼÊô,TaxusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼¡ÉÏÆ¤Áö,MyoepitheliomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄáĪ˾͡,NimustineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´Ö²Ú,RoughÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« RASSF1A»ùÒò,RASSF1A geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁܰͽáÇгý,LymphadenectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«